Aspiriant, a West L.A. independent wealth management firm that oversees $7 billion in client assets, announced the launch of its first mutual fund.
The company said the Aspiriant Risk-Managed Global Equity Fund would attempt to keep people invested during times of large market downturns by smoothing out the swings in the market via its mix of investments. Initially, it will be available exclusively to Aspiriant investment advisory clients but later this year would open to the public through its RMEAX ticker symbol.
“The fund is a public equity solution for individual client portfolios,” said Chief Investment Officer Jason Thomas, who will oversee the sub-advisors in the fund. “In addition to a quantitative equity strategy, the fund applies a number of sophisticated risk management techniques previously unavailable to individual investors at a reasonable cost.”
Aspiriant was created in 2008 when Quintile Wealth Management of Los Angeles merged with Kochis Fitz of San Francisco. It went national in 2010 with the acquisition of Deloitte Investment Advisors of New York, which had operations in the Northeast and Midwest. It currently manages assets for about 800 individuals and families.
You May Also Like
- Aspiriant Acquires Glowacki Group
- Wealth Manager Changes Name
- Aspiriant Acquires Deloitte Unit
- Merger Plan Continues to Come Together for Investment Firm
- West L.A. Wealth Management Firm Aspiriant Merges with Bay Area Firm
- Rob Francais
- The Most Influential Wealth Managers In Los Angeles: BRIAN PARKER
- Unique Period in History Unites Wealth Managers